Introduction
Bullous systemic lupus erythematosus (BSLE) is a rare disease in adults, affecting less than 5% of SLE patients. 1 Skin involvement is characterized by the presence of localized or generalized vesicles and bullous lesions arising on normal or erythematous skin. Lesions predominantly affect the trunk and limbs, but may involve any area of the body, including face and mucous membranes. 2, 3 Histopathology includes subepidermal blistering with neutrophilic microabscesses in dermal papillae and a perivascular and periadnexal infiltrate with lymphocytes and neutrophils. Direct immunofluorescence (DIF) examination of compromised skin reveals IgG, IgA, IgM and complement deposition along the epidermal basement membrane. 3, 4 The presence of circulating antibodies against the dermal side of the basement membrane zone (BMZ) has also been reported. 1, 3, 5 BSLE is diagnosed according to Camisa and Sharma diagnostic criteria that include: diagnosis of SLE based on American College Criteria (ACR), 6 presence of vesicles and bullae, particularly located in sun-exposed sites, typical histopathology findings and deposition of immunoglobulins at the BMZ. 7, 8 Of note, BSLE has rarely been described in the pediatric lupus population and to our knowledge the prevalence of childhood-onset BSLE has not been reported. From January 1983 to November 2013, 303 childhood-onset SLE (c-SLE) patients were followed at the Pediatric Rheumatology Unit of the Children's Institute of Hospital das Clı´nicas da Faculdade de Medicina da Universidade de Sa˜o Paulo. Three of them (1%) presented BSLE and are described herein (Table 1) .
Case report

Case 1
A boy aged 10 years and 5 months presented fever, conjunctival hyperemia and arthritis affecting the knees, elbows and wrists associated with generalized tense vesicles and bullae for a period of 30 days. Lesions developed on apparently normal skin and affected the face (Figure 1(a) ), oral mucosa and trunk. Biopsy of a vesicle on the trunk showed a subepidermal blister evidencing microabscesses in dermal papillae and perivascular inflammatory infiltrates (HEX100) (Figure 1(b) ).
DIF revealed deposits of IgG, IgA and IgM at BMZ. Indirect immunofluorescence (IIF) was not performed. After 1 month, he presented oral ulcers, and pleural and peritoneal effusions. Laboratory findings showed hemoglobin 9.3 g/dl, white blood cell (WBC) 7300/mm 3 (73% neutrophils, 21% lymphocytes and 6% monocytes), platelets 398,000/mm 3 , erythrocyte sedimentation rate (ESR) 15 mm/1 st hour, C-reactive protein (CRP) 6.2 mg/l (normal < 5), urea 32 mg/dl (normal 10-42), creatinine 0.86 mg/dl (normal 0.6-0.9), C3 45 mg/dl (normal range 50-180) and C4 6 mg/dl (normal range 10-40). Urinalysis showed leukocytes 1000/ml and erythrocytes 21,000/ml. 9 score was 18. He was treated with methylprednisolone pulse therapy (30 mg/kg/day for 3 consecutive days), followed by prednisone (1.0 mg/kg/day), hydroxychloroquine (4.0 mg/kg/day) and dapsone (1.5 mg/kg/day). After 1 month, the vesicles and bullous lesions improved immensely with mild residual pigmentary changes. The SLEDAI-2K 9 was 2.
Case 2
A 10-year-old girl presented recurrent bullae and vesicular lesions on the trunk for a period of 2 months. Two months later, she presented oral ulcers, arthritis on the knees, pericarditis, edema on the face and lower limbs, and arterial hypertension. A skin biopsy showed neutrophilic bullous dermatitis with subepidermal cleavage. DIF revealed deposits of IgG, IgM, IgA and C3 at the dermal side of the BMZ fulfilling Camisa and Sharma's diagnostic criteria for bullous lupus. 8 IIF on salt-split skin was negative. Laboratory findings showed hemoglobin 10.9 g/dl, WBC 7590/mm 3 (87% neutrophils, 9% lymphocytes and 4% monocytes) and platelets 354,000/mm 3 . CRP was 12.5 mg/dl, ESR 14 mm/1 st hour, C3 38 mg/dl and C4 3 mg/dl. Urinalysis showed leukocytes 30,000/ml and erythrocytes 20,000/ml. Proteinuria was 0.67 g/day. Immunological tests showed positive ANA 1:1280 (speckled pattern), and positive anti-dsDNA, anti-Sm, anti-Ro/SSA autoantibodies. The renal biopsy showed focal proliferative lupus nephritis. The SLEDAI-2K 9 score was 24. She was treated with methylprednisolone pulse therapy (30 mg/kg/day for 3 consecutive days), followed by prednisone (1.0 mg/kg/day), monthly intravenous cyclophosphamide (500-1000 mg/m 2 ) and hydroxychloroquine (4.5 mg/kg/day). After 4 months, she progressively improved, with complete resolution of vesicles and bullous lesions with residual pigmentary changes. The SLEDAI-2K 9 was 6.
Case 3
A girl aged 5 years and 8 months presented with fever, and vesicles and bullous lesions on the neck, lower limbs, and oral mucosa for a period of 2 months. Skin biopsy showed subepidermal blister with neutrophils-predominant inflammation in the upper dermis, and DIF showed deposition of IgA, IgM and IgG at the BMZ and a positive IIF on salt-split skin. Two months later, the patient developed eyelid edema and oral ulcers. Laboratory findings revealed hemoglobin 7.9 g/dl, WBC 10,700/mm 3 (65% neutrophils, 30% lymphocytes and 1% eosinophils), and platelets 546,000/mm 3 . CRP was 12.5 mg/dl, C3 38 mg/dl and C4 5 mg/dl. Proteinuria was 0.6 g/day and urinalysis showed granular cast. Immunological tests showed positive ANA 1:200 (homogenous pattern) and anti-Sm autoantibodies. Anti-dsDNA and anti-Ro/SSA antibodies were negative. The renal biopsy revealed mesangial proliferative lupus nephritis. She fulfilled Camisa and Sharma's diagnostic criteria. 8 The SLEDAI-2K 9 was 14. She was treated with three intravenous methylprednisolone pulses, prednisone (2.0 mg/kg/day), hydroxychloroquine (4.5 mg/kg/day) and dapsone (1.5 mg/kg/day). After 4 months, she presented progressive improvement of the vesicles and bullous lesions with residual scarring. The SLEDAI-2K 9 was 6.
Discussion
BSLE has rarely been reported as an initial manifestation of SLE in children and adolescents, 1 and, to our knowledge, there is no study that has evaluated the prevalence of this cutaneous involvement in the c-SLE population. Over the last 30 years, the prevalence of BSLE in childhood was 1% in our tertiary University Hospital. Vesiculobullous skin involvement was the first disease manifestation in all three cases. Tense vesicles and bullae usually affect both sunexposed and non-exposed areas and may be widespread, more rarely involving mucous membranes. 4 This autoimmune blister disorder can occur isolated or in conjunction with other lupus manifestations, mainly nephritis and serositis, 1 as observed herein. In addition, in all our cases, the presence of BSLE was associated with moderate to severe disease activity, since the patients had SLEDAI-2K 9 score greater than 8.
To confirm the BSLE diagnosis, it is mandatory to perform a biopsy as well as immunofluorescence testing of the affected skin. The histological pattern demonstrates a subepidermal blistering with neutrophil-predominant infiltrate within the upper dermis. 8, 10 DIF can show deposits of IgG, IgA, IgM and complement along the epidermal basement membrane. 4, 8, 10 The presence of circulating antibodies against the dermal side of the BMZ is most frequently reported, and rarely immunoreactants are seen on the roof of the blister. Of note, differential diagnoses of BSLE includes a variety of chronic blistering diseases, such as epidermolysis bullosa acquisita, dermatitis herpetiformis, bullous pemphigoid, and linear IgA disease, among others, and should be accurately differentiated through the clinical features and immunohistochemical procedures. 1, 7 Nevertheless, primarily blistering diseases have been anecdotally reported to occur in patients with both cutaneous and SLE. The presence of bullae in conjunction with systemic manifestations and specific autoantibodies should serve as an alert for BSLE diagnosis.
Regarding treatment, dapsone is the drug of choice for BSLE. However, there are patients where dapsone alone is not sufficient. Other treatments include corticosteroids, antimalarial drugs and immunosuppressive agents, 10, 11 especially in systemic cases with severe nephritis, 12 as observed in case 2.
Diagnostic criteria for BSLE were initially proposed by Camisa and Sharma 8 and were revised by Gammon and Briggaman to include the presence of circulating antibodies to type VII collagen, 13 which is the major component of anchoring fibrils at the dermal-epidermal junction. Therefore, the loss of integrity of the dermal-epidermal junction may cause blisters. 5 The IIF salt-split skin method is also used to detect this antibody, 2,3 as in our cases 2 and 3.
In conclusion, here we report three cases of BSLE as the first manifestation of SLE. A diagnosis of SLE should always be considered in children with recurrent tense vesiculobullous lesions with or without systemic manifestations.
